参附注射液对前列腺癌PC-3细胞凋亡诱导的影响  被引量:6

Shenfu Injection induces the apoptosis of prostate cancer PC-3 cells

在线阅读下载全文

作  者:吕立国[1] 张娴[2] 陈志强[1] 白遵光[1] 吴巧玲[3] 王昭辉[1] 代睿欣[1] 张秀琼[1] 李思逸[1] 王树声[1] 

机构地区:[1]广东省中医院泌尿外科,广东广州510120 [2]广东省中医院中心实验室,广东广州510120 [3]广东省中医院肿瘤科,广东广州510120

出  处:《中华男科学杂志》2014年第6期539-543,共5页National Journal of Andrology

基  金:广东省科技计划项目(2012B061700035);广州中医药大学科研创新基金课题(10CX038)~~

摘  要:目的:研究参附注射液(SF)对人前列腺癌PC-3细胞凋亡的影响及可能机制。方法:实验设立对照组和SF 50、100、200μl/ml组,Annexin V/PI染色流式细胞术检测细胞凋亡,RT-PCR检测p53 mRNA表达。结果:与对照组比较,作用24、48、72 h后,SF 50、100、200μl/ml组PC-3细胞存活率显著减少(P均<0.05)。SF各组24 h存活率分别为(93.76±2.63)%、(81.21±1.80)%、(18.01±3.84)%;48 h存活率分别为(94.67±1.11)%、(78.33±2.89)%、(10.34±1.44)%;72 h存活率分别为(91.30±0.47)%、(36.67±1.56)%、(1.33±0.32)%,呈浓度和时间依赖性。作用48 h后,p53 mRNA表达明显升高(P<0.05)。结论:SF可以诱导PC-3细胞凋亡,其作用机制可能与p53表达增高相关。Objective : To study the effect of Shenfu Injection (SF) on the apoptosis of prostate cancer PC-3 cells and its possibale mechanism. Methods : We divided prostate cancer PC-3 cells into a blank control group and three experimental groups, the latter treated with SF at 50, 100, and 200 μl/ml, respectively, for 24, 48, and 72 hours. Then we determined the proliferation of the cells by MTT assay, measured their apoptosis by Annexin V/PI flow cytometry, and detected the expression of P53 mRNA by RT- qPCR. Results: Compared with the blank control group, the survival rates of the prostate cancer PC-3 cells in the 50, 100, and 200 μl/ml SF groups were (93.76 ±2.63)%, (81.21 ±1.80)% and (18.01 ±3.84)% at24 hours, (94.67 ±1. 11)%, (78.33 ± 2.89 ) % and ( 10.34 ± 1.44 ) % at 48 hours, and (91.30 ±0. 47) %, (36. 67 ± 1.56) % and ( 1.33 ± 0.32) % at 72 hours, all significantly increased in a dose- and time-dependent manner (P 〈 0.05). The expression of p53 mRNA was also maikedly increased in all the three experimental groups at 48 hottrs ( P 〈 0.05 ). Conclusion: SF can inhibit the proliferation and induce the apeptosis of PC-3 cells, which may due to its upregulation of the p53 mRNA expression.

关 键 词:参附注射液 前列腺癌 PC-3细胞 细胞凋亡 

分 类 号:R737.25[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象